scispace - formally typeset
M

María M. Escribese

Researcher at CEU San Pablo University

Publications -  63
Citations -  1620

María M. Escribese is an academic researcher from CEU San Pablo University. The author has contributed to research in topics: Allergy & Medicine. The author has an hindex of 20, co-authored 50 publications receiving 1174 citations. Previous affiliations of María M. Escribese include Carlos III Health Institute & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Microbiome and Allergic Diseases.

TL;DR: Interventions with probiotics, prebiotics, and/or synbiotics seem promising for the development of a preventive therapy by restoring altered microbiome functionality, or as an adjuvant in specific immunotherapy.
Journal ArticleDOI

Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study.

TL;DR: The Viral Immunity and Pregnancy study shows that pregnancy is not a period of immunosuppression but an alteration in immune priorities characterized by a strengthening of innate immune barriers and a concomitant reduction in adaptive/inflammatory immunity in the later stages of pregnancy.
Journal ArticleDOI

VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses

TL;DR: It is shown that alpha 4 beta 1 is recruited to both human and murine antigen-dependent immune synapses, when the antigen-presenting cell is a B lymphocyte or a dendritic cell, colocalizing with LFA-1 at the peripheral supramolecular activation complex.
Journal ArticleDOI

Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways

TL;DR: The data indicate that GM-M Ø and M-MØ display distinct bioenergetic profiles, and that hypoxia triggers a transcriptomic switch in macrophages by promoting a HIF-1α/HIF-2α-dependent increase in ECAR.
Journal ArticleDOI

Recent developments and highlights in biomarkers in allergic diseases and asthma.

TL;DR: In the last years, significant research resources have been put in the identification of valid biomarkers for asthma and allergic diseases with focus on the biomarkers with higher clinical applicability, which are summarized in this review.